Skip to content

Clinical trials

Completed Schizophrenia trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Status: Completed Country / region: Japan Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20064
20072
20084
20091
20106
20113
20129
20131
20144
20161
20171
20191
20203
20213
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed48

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Co., Ltd.9
Sumitomo Pharma Co., Ltd.7
Tanabe Pharma Corporation6
Boehringer Ingelheim4
Eli Lilly and Company4
Hoffmann-La Roche4
Janssen Pharmaceutical K.K.4
Karuna Therapeutics, Inc., a Bristol Myers Squibb company2
Astellas Pharma Inc1
Chiba University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia48
Mental Disorders5
Psychotic Disorders2
Bipolar Disorder1
Sleep Initiation and Maintenance Disorders1

Trials

Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.